BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10177743)

  • 1. Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing--FDA. Proposed rule.
    Fed Regist; 1998 Mar; 63(43):10792-8. PubMed ID: 10177743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18230-4. PubMed ID: 11010623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematology and pathology devices; reclassification of the automated differential cell counter. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(9):1606-7. PubMed ID: 11800006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; classification/reclassification; restricted devices; analyte specific reagents--FDA. Final rule.
    Fed Regist; 1997 Nov; 62(225):62243-60. PubMed ID: 10177056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General hospital and personal use devices: proposed classification of liquid chemical sterilants and general purpose disinfectants--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(215):59917-21. PubMed ID: 10187388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; classification/reclassification of immunohistochemistry reagents and kits--FDA. Final rule.
    Fed Regist; 1998 Jun; 63(106):30132-42. PubMed ID: 10179865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General hospital and personal use devices; classification of the Apgar timer, lice removal kit, and infusion stand--FDA. Proposed rule.
    Fed Regist; 1998 Mar; 63(46):11632-3. PubMed ID: 10177746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthopedic devices: classification and reclassification of pedicle screw spinal systems--FDA. Final rule.
    Fed Regist; 1998 Jul; 63(143):40025-41. PubMed ID: 10181517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
    Yin L
    J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(40):9530-2. PubMed ID: 12617085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(226):70305-7. PubMed ID: 11503713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; neurological devices; classification of cranial orthosis--FDA. Final rule.
    Fed Regist; 1998 Jul; 63(146):40650-2. PubMed ID: 10181519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.